Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Ticagrelor, Brillinta, is the newest antiplatelet agent on the market. Ticagrelor is a reversible nonthienopyridine P2Y12 receptor antagonist that prevents signal transduction and platelet activation.
Feature | Antiplatelet and Anticoagulation Therapies | Nicole Fornell, Pharm D

The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus ...

Home August 28, 2012
Home
Feature

August 23, 2012 — Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, finds that ...

Home August 23, 2012
Home
Technology

August 23, 2012 – Philips Healthcare and Corindus Vascular Robotics announced a distribution agreement for Corindus’ ...

Home August 23, 2012
Home
News

August 22, 2012 — Placement of an endovascular stent has become a common procedure for successfully reopening blocked ...

Home August 22, 2012
Home
Feature | Dave Fornell

August 22, 2012 — Comedian Rosie O'Donnell’s heart attack last week is helping increase public education about how women ...

Home August 22, 2012
Home
News

August 20, 2012 — Abbott today announced that the Xience Xpedition everolimus-eluting coronary stent system received CE ...

Home August 20, 2012
Home
News

August 15, 2012 — Sound Interventions Inc. has released three-month data from the company's first-in-human clinical ...

Home August 15, 2012
Home
News

August 15, 2012 — Previously unreleased three-year data from the Zilver PTX randomized controlled trial of paclitaxel ...

Home August 15, 2012
Home
TAVR, EVAR Vascular Closure Device May Eliminate Need for Surgical Cut-Down
Feature | Dave Fornell

Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR) ...

Home August 15, 2012
Home
News

August 14, 2012 — The next five years will see many hospitals in Europe overcoming the high cost and complexity of ...

Home August 14, 2012
Home
Technology

August 14, 2012 — The U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Stryker ...

Home August 14, 2012
Home
News

August 14, 2012 — The U.S. Food and Drug Administration (FDA) is hosting a public workshop that examines use of ...

Home August 14, 2012
Home
Feature

August 13, 2012 — Providers are increasingly focused on using interventional labs in a hybrid operating room (OR) enviro ...

Home August 13, 2012
Home
News

August 9, 2012 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers and patients that the ...

Home August 09, 2012
Home
Technology

Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...

Home August 08, 2012
Home
Subscribe Now